Laughter Yoga's Impact on Traumatic Childbirth Preparation
Launched by ANKARA UNIVERSITY · Oct 27, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how laughter yoga can help first-time pregnant women prepare for childbirth and reduce feelings of fear, distress, and depression related to pregnancy. The research will involve two groups of women: one group will participate in laughter yoga sessions combined with standard birth preparation training, while the other group will only receive the standard training. The study aims to see if laughter yoga can improve how women feel about childbirth and their connection with their baby.
To be eligible for this trial, women must be at least 18 years old and between 20 to 26 weeks pregnant with their first baby. They should also be able to read and write in Turkish and agree to participate in the study. Participants will complete several questionnaires at different stages: before the training starts, immediately after, and one month later. This will help researchers understand the effects of the laughter yoga sessions on their experiences and feelings about childbirth. It's important to note that women with high-risk pregnancies or certain medical and psychological conditions will not be able to take part in this study.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged 18 years and older.
- • Pregnant individuals between 20-26 weeks of gestation (Childbirth preparation training should begin by the 20th week of pregnancy according to the recommendations of the Turkish Ministry of Health, and since the training is planned to last 4 weeks, participants will be recruited before entering the third trimester).
- • First-time pregnancies.
- • Individuals who understand, speak, and can read and write in Turkish.
- • Women who consent to participate in the study.
- Exclusion Criteria:
- • Women with high-risk pregnancies (such as placenta previa, history of antepartum bleeding, ruptured membranes, preeclampsia, hypertension, diabetes, or other medical conditions, intrauterine growth restriction, multiple pregnancies, fetal anomalies, or any contraindications for normal vaginal delivery, substance or alcohol dependence, chronic illnesses, etc.).
- • Individuals diagnosed with psychiatric disorders.
- • Those who have received psychotherapy or medication within the last six months prior to the study.
- • Pregnant women with prior training or experience in cognitive awareness-based or mind-body methods.
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
İlknur Gönenç, Assoc. Prof. Dr.
Study Chair
Ankara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported